More-Expensive SMA Medication Use Led to Lower Health Care Resource Utilization
Patients with spinal muscular atrophy (SMA) treated with a more expensive medication were found to have higher pharmacy costs but lower SMA-related health care resource utilization and medical costs compared with patients receiving standard-of-care nusinersen monotherapy.
Source: ajmc.com